Array BioPharma Provides Updated Results From Phase 3 Columbus Trial

Array BioPharma Inc. (ARRY) on Monday announced updated results from the Phase 3 COLUMBUS trial in BRAF-mutant advanced melanoma.

from RTT - Biotech https://ift.tt/2Ln7o4P
via IFTTT